Michael Nestor insider trades: Impax Laboratories (IPXL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 31, 2017 | IPXL | ↓ Sell | 1,130 | $15.00 | $17K | Direct | Jun 1, 2017 (1d) |
| May 17, 2017 | IPXL | ↓ Sell | 857 | $16.48 | $14K | Direct | May 17, 2017 (0d) |
| May 12, 2017 | IPXL | ↓ Sell | 700 | $17.11 | $12K | Direct | May 15, 2017 (3d) |
| Sep 10, 2015 | IPXL | ↓ Sell | 5,000 | $43.56 | $218K | Direct | Sep 14, 2015 (4d) |
| Aug 13, 2010 | IPXL | ↑ Buy | 1,645 | $16.06 | $26K | By Spouse | Aug 17, 2010 (4d) |
| Mar 13, 2009 | IPXL | ↑ Buy | 2,000 | $5.59 | $11K | By Spouse | Mar 17, 2009 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael Nestor's insider trades
Michael Nestor is President, Impax Specialty at Impax Laboratories (IPXL). Since Mar 13, 2009, Michael has reported 2 open-market purchases worth $38K and 4 sales worth $261K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (28 filings), grants and awards (9 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IPXL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.